Department of Ophthalmology and Vision Sciences.
Department of Ophthalmology and Vision Sciences.
Can J Ophthalmol. 2021 Dec;56(6):379-384. doi: 10.1016/j.jcjo.2021.01.008. Epub 2021 Feb 3.
To determine the proportion of glaucoma patients in Ontario aged 25-64 who lack insurance coverage for glaucoma medications and to assess the frequency of cost-related nonadherence to glaucoma medications.
Cross-sectional study.
Glaucoma patients on medication from 2 glaucoma clinics in Toronto, Ontario.
100 consecutive glaucoma patients aged 25-64 (not entitled to provincial drug benefit) and 100 consecutive glaucoma patients aged 65+ (entitled to provincial drug benefit), all on topical glaucoma therapy, completed a standardized questionnaire. Questions included insurance coverage for glaucoma medications, cost concerns when paying for glaucoma medications, cost-related nonadherence, and sociodemographics.
25.8% of those aged 25-64 express concerns about the cost of their glaucoma medications compared to 7.1% of those aged 65+ (p < 0.001). Patients aged 25-64 were also significantly more likely to report at least one form of cost-related nonadherence (15.5% vs 2.0%, p = 0.001) and significantly more likely to report missing eye drops in a given week than patients aged 65+ (32.0% vs 16.7%, p = 0.01). 17% (95% confidence interval 11%-26%) of patients aged 25-64 self-reported having no insurance coverage for their glaucoma medications. Of those with coverage, the most common source of insurance was employer-sponsored (68.6%) with 44% requiring a copayment. The average copayment was $18 (range $2-$250) for those aged 25-64 compared with $5 in the 65+ group (range $0.62-$100).
17% of glaucoma patients aged 25-64 do not have coverage for their drops. One in four expressed concerns about the cost of their glaucoma medications, and 15.5% reported cost-related nonadherence.
确定安大略省 25-64 岁的青光眼患者中缺乏青光眼药物保险覆盖的比例，并评估与药物费用相关的青光眼药物不依从的频率。
横断面研究。
来自安大略省多伦多的 2 家青光眼诊所正在接受药物治疗的 100 例连续青光眼患者。
100 例连续的 25-64 岁（无资格享受省级药物福利）和 100 例连续的 65 岁以上（有资格享受省级药物福利）的青光眼患者，均接受局部青光眼治疗，完成了标准化问卷。问题包括青光眼药物的保险覆盖范围、支付青光眼药物费用时的费用问题、与费用相关的不依从性以及社会人口统计学。
25.8%的 25-64 岁患者对其青光眼药物费用表示担忧，而 65 岁以上患者的这一比例为 7.1%（p < 0.001）。25-64 岁的患者报告至少有一种形式的与费用相关的不依从的可能性也明显更高（15.5%比 2.0%，p = 0.001），并且比 65 岁以上的患者更有可能在给定的一周内漏滴眼药水（32.0%比 16.7%，p = 0.01）。17%（95%置信区间 11%-26%）的 25-64 岁患者报告他们的青光眼药物没有保险。在有保险的患者中，最常见的保险来源是雇主赞助（68.6%），其中 44%需要自付额。对于 25-64 岁的患者，平均自付额为 18 美元（范围为 2-250 美元），而 65 岁以上的患者为 5 美元（范围为 0.62-100 美元）。
17%的 25-64 岁青光眼患者没有眼药水保险。四分之一的人对他们的青光眼药物费用表示担忧，15.5%的人报告存在与费用相关的不依从。
